Axsome signals 1 NDA per year through 2030 as AXS-12 targets May 1, 2027 PDUFA

NDA FilingAXS-12Positive

AI Analysis

Summary

Axsome Therapeutics announced plans to file one NDA per year through 2030, with AXS-12 targeting a May 1, 2027 PDUFA date. This signals the company's expected regulatory pipeline progression over the next several years.

Importance:7/10

Sentiment:

0.60

NDAPDUFApipelineregulatory pathway

Related Companies

$AXSM

Read the original article

Published by Seeking Alpha Healthcare on August 10, 2026 4:09 PM

Read Original